News

CellVoyant leverages AI and live-cell imaging to predict cellular behavior, transforming cell therapy development and making ...
was awarded to the King Faisal Specialist Hospital & Research Centre for revolutionising organ transplantation through ...
David M. Weiner, MD, Rejoins Chemomab as Interim Chief Medical Officer, Bringing Extensive Biotechnology and Pharmaceutical ...
The company's cancer cell therapy Carvykti, which it makes in partnership with Legend Biotech, brought in sales of $369 million, above estimates of $324 million. Quarterly sales of J&J's cancer drugs ...
Keith Coursin, Vonnie Estes, Patrick Hidder, Andrew Horowitz, Julia Kurnik and Michael Yates are joining the board to help ...
New York State is a top recipient of NIH funding and is expected to lose about $880 million.
Mark Esser, an executive at Big Pharma firm AstraZeneca, has been named the inaugural leader of UVa's future Manning ...
Students of Amity School of Fashion Technology at Amity University Rajasthan showcased their creativity and innovation at the ...
NeuroSense Therapeutics, Ltd. , a leading clinical-stage biotechnology company focused on developing treatments for severe neurodegenerative diseases, today announced promising new findings from its ...
Global business visionary, inventor, and philanthropist leaves behind a legacy of improving billions of lives around the ...
Just over 10 years since first breaking into the top 30, Duke Engineering’s graduate program continues to climb amongst its ...
Marks is highly regarded by former FDA leaders and biotech industry executives ... In Episode 8 of "Sarra Sounds Off," Gregg ...